Title:Narrative on Hydrogen Therapy and its Clinical Applications: Safety and Efficacy
Volume: 28
Issue: 31
Author(s): Aqeel Ahmad, Atif Amin Baig, Mubashir Hussain, Muhammad Usama Saeed, Muhammad Bilal, Naveed Ahmed, Hitesh Chopra, Muhammad Hassan, Mahesh Rachamalla, Sravan Kumar Putnala, Muniba Khaliq, Zirwah Tahir and Mohammad Amjad Kamal*
Affiliation:
- Institutes for Systems Genetics, Frontiers Science Center for Disease-related
Molecular Network, West China Hospital, Sichuan University, Sichuan, China
- King Fahd Medical Research Center, King
Abdulaziz University, Jeddah, Saudi Arabia
- Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International
University, Ashulia, Bangladesh
- Enzymoics, 7 Peterlee Place, Hebersham, NSW 2770; Novel Global Community Educational
Foundation, Sydney, Australia
Keywords:
Hydrogen therapy, molecular hydrogen, the efficacy of hydrogen therapy, therapeutic, hydrogen therapy in disease, reducing agent.
Abstract: Molecular hydrogen proved itself as a novel therapeutic candidate and has been thriving from the
beginning with its potential clinical significance, higher affinity, and cellular integrity and permeability. Hydrogen
Therapy (HT) has gained scientists' attention with the proven clinical ability to attenuate chronic inflammation,
diminish oxidative stress, restrict apoptosis, minimize cellular injury, and refine tissue functioning. Therapeutic
Implementation of H2 for disease prevention and treatment is a newly emerging field with limited
knowledge available on formulations, tissue-specific effects, efficacy, and safety. This article will discuss HT's
therapeutic potential for its efficacy and safety in cardiovascular, respiratory, hematological, metabolic, infectious,
and neurodegenerative disorders. In addition to this, the molecular mechanisms and nanotechnological
implications of hydrogen therapy will be discussed in detail. Finally, the article will provide insight into advancements
and automation, future perspectives, and recommendations. There is a need to study and conduct
higher-scale trials targeting personalized treatments under molecular and genetic vitals.